Association of Coronary Artery Severity and Late In-Stent Restenosis: An Angiographic Imaging Study

Berk, Gül İlayda; Akbulut, Tayyar; Şaylık, Faysal; Sipal, Abdulcabbar; Erdal, Emrah

doi:10.1177/00033197221150953

Cited by 4 publications

(2 citation statements)

References 34 publications

(43 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lately, researchers observed that patients who developed lesions in different vessels were vulnerable to ISR [18]. The degree of C-reactive protein is a novel biomarker of ISR supported by several evidences (19). Additionally, hereditary polymorphism may be a capability in the progress of ISR, as studies have shown that some SNPs in CD18 and MMP13 genes increase the risk of ISR (20).…”

Section: Discussionmentioning

confidence: 99%

In Stent Restenosis (Isr) in Patients Undergoing Percutaneous Coronary Intervention (Pci) for Coronary Artery Disease (Cad)

ULLAH,

ARSHAD,

HUSSAIN

2024

Biol Clin Sci Res J

View full text Add to dashboard Cite

In-stent restenosis (ISR) remains a significant clinical challenge in patients undergoing percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Objectives: The main aim of the study is to find the In-Stent Restenosis (ISR) in patients undergoing percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Methods: This cross-sectional study was conducted at Prime Teaching Hospital Peshawar from January 2023 till December 2023. Data were collected from 80 patients from both genders. Patients who underwent PCI for CAD and developed ISR, as confirmed by angiographic or intravascular imaging studies, were included. Data were collected in a systematically designed performance. Information was collected from electronic medical records, angiographic reports, and procedural databases. Results: Data were collected from 80 patients according to inclusion criteria. The mean age of the patients was 65.09±8.5 years. There were 52 (65%) male and 48 (35%) female patients. Hypertension was present in 60 (75%), dyslipidemia in 48(60%) and DM in 36 (45%) patients. There was a significant association between older age and increased likelihood of ISR development post-PCI (Mean age ISR: 68.01 ± 7.2 years vs. No ISR: 62.39 ± 9.1 years, p=0.02). However, gender did not significantly influence ISR occurrence (71% male ISR vs. 62% male No ISR, p=0.42). Conclusion: It is concluded that ISR represents a significant challenge in patients post-PCI for CAD, with a substantial incidence observed in this study. Older age, diabetes mellitus, and DES implantation were identified as essential contributors to ISR development.

show abstract

Section: Discussionmentioning

confidence: 99%

In Stent Restenosis (Isr) in Patients Undergoing Percutaneous Coronary Intervention (Pci) for Coronary Artery Disease (Cad)

ULLAH,

ARSHAD,

HUSSAIN

2024

Biol Clin Sci Res J

View full text Add to dashboard Cite

show abstract

“…4 However, considering the millions of DES implants each year, ISR remains a huge challenge. 5 COPD is a slowly progressing lung disease that trigger systemic inflammation. The mortality rate of this disease is high.…”

Section: Introductionmentioning

confidence: 99%

Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention

Hou,

Su,

Zhao

et al. 2023

IJGM

View full text Add to dashboard Cite

Objective Chronic obstructive pulmonary disease (COPD) is a prevalent chronic respiratory disease that poses a significant health risk to individuals. Patients with COPD are predisposed to a higher incidence of coronary artery disease (CAD) than the general population. This study aims to investigate the correlation between COPD and the incidence of in-stent restenosis (ISR) after percutaneous coronary intervention (PCI). Methods This study retrospectively analyzed the clinical data and laboratory test results of patients who underwent PCI at our hospital between January 2018 and December 2021 to investigate the relationship between COPD and drug-Eluting Stents (DES) postoperative ISR. We employed the best subset method to select the most suitable combination of predictive factors, utilizing the data, and verified the precision of the model by means of internal validation. We ultimately assessed the performance of the prediction model using an ROC curve. Results The research indicates that COPD is an independent risk factor for ISR after PCI (OR=2.437, 95% CI [1.336, 4.495], P=0.004). The analysis revealed an area under the receiver operating characteristic (ROC) curve of 0.783 for the training group and 0.705 for the testing group, indicating a model fitting for both groups (both > 0.5). Conclusion COPD history is a dependable predictor of stent restenosis post percutaneous coronary intervention.

show abstract

Comment on the Association of Coronary Artery Severity and Late In-Stent Restenosis: An Angiographic Imaging Study

Murat,

Gorenek

2024

Angiology

View full text Add to dashboard Cite

Association of Coronary Artery Severity and Late In-Stent Restenosis: An Angiographic Imaging Study

Cited by 4 publications

References 34 publications

In Stent Restenosis (Isr) in Patients Undergoing Percutaneous Coronary Intervention (Pci) for Coronary Artery Disease (Cad)

In Stent Restenosis (Isr) in Patients Undergoing Percutaneous Coronary Intervention (Pci) for Coronary Artery Disease (Cad)

Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention

Comment on the Association of Coronary Artery Severity and Late In-Stent Restenosis: An Angiographic Imaging Study

Contact Info

Product

Resources

About